Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE Cause Febrile bone marrow aplasia? 733 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 733 reports of Febrile bone marrow aplasia have been filed in association with CYTARABINE (cytarabine). This represents 1.7% of all adverse event reports for CYTARABINE.

733
Reports of Febrile bone marrow aplasia with CYTARABINE
1.7%
of all CYTARABINE reports
31
Deaths
640
Hospitalizations

How Dangerous Is Febrile bone marrow aplasia From CYTARABINE?

Of the 733 reports, 31 (4.2%) resulted in death, 640 (87.3%) required hospitalization, and 68 (9.3%) were considered life-threatening.

Is Febrile bone marrow aplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 733 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE Cause?

Febrile neutropenia (6,142) Off label use (4,183) Pyrexia (2,992) Neutropenia (2,558) Disease progression (2,352) Drug ineffective (2,281) Thrombocytopenia (2,148) Sepsis (2,013) Myelosuppression (1,869) Product use in unapproved indication (1,619)

What Other Drugs Cause Febrile bone marrow aplasia?

VINCRISTINE (912) METHOTREXATE (880) CYCLOPHOSPHAMIDE (839) PEGASPARGASE (668) DOXORUBICIN (623) DEXAMETHASONE (555) CARBOPLATIN (440) ETOPOSIDE (413) HYDROCORTISONE (379) RITUXIMAB (313)

Which CYTARABINE Alternatives Have Lower Febrile bone marrow aplasia Risk?

CYTARABINE vs CYTARABINE\DAUNORUBICIN CYTARABINE vs DABIGATRAN CYTARABINE vs DABIGATRAN ETEXILATE CYTARABINE vs DABRAFENIB CYTARABINE vs DABRAFENIB\TRAMETINIB

Related Pages

CYTARABINE Full Profile All Febrile bone marrow aplasia Reports All Drugs Causing Febrile bone marrow aplasia CYTARABINE Demographics